Probiotics and COVID-19: one size does not fit all

Lancet Gastroenterol Hepatol. 2020 Jul;5(7):644-645. doi: 10.1016/S2468-1253(20)30122-9. Epub 2020 Apr 25.

Authors

Joyce W Y Mak¹, Francis K L Chan¹, Siew C Ng²

Affiliations

¹ Center for Gut Microbiota Research, Department of Medicine and Therapeutics, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
² Center for Gut Microbiota Research, Department of Medicine and Therapeutics, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China. Electronic address: siewchienng@cuhk.edu.hk.

No abstract available

Publication types

Letter

MeSH terms

Betacoronavirus*
COVID-19
China
Coronavirus Infections / complications
Coronavirus Infections / drug therapy
Coronavirus Infections / microbiology
Coronavirus Infections / therapy*
Diarrhea / chemically induced
Diarrhea / microbiology
Diarrhea / therapy
Humans
Pandemics
Pneumonia, Viral / complications
Pneumonia, Viral / drug therapy
Pneumonia, Viral / microbiology
Pneumonia, Viral / therapy*
Probiotics / therapeutic use*
SARS-CoV-2
Treatment Outcome